These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15066668)

  • 21. HPMC capsules: current status and future prospects.
    Al-Tabakha MM
    J Pharm Pharm Sci; 2010; 13(3):428-42. PubMed ID: 21092714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
    Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K
    Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal versus radial effects of hydroxypropylmethylcellulose on gastrointestinal glucose absorption in dogs.
    Reppas C; Greenwood DE; Dressman JB
    Eur J Pharm Sci; 1999 Jul; 8(3):211-9. PubMed ID: 10379044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged-release hard gelatin capsules of furosemide for the treatment of dogs.
    Smal J; Haapala O; Marvola M; Kuusela S; Happonen I
    J Vet Pharmacol Ther; 1995 Feb; 18(1):17-23. PubMed ID: 7752301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: an investigation into the mechanisms governing drug release.
    Zema L; Maroni A; Foppoli A; Palugan L; Sangalli ME; Gazzaniga A
    J Pharm Sci; 2007 Jun; 96(6):1527-36. PubMed ID: 17094127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enteric coated HPMC capsules designed to achieve intestinal targeting.
    Cole ET; Scott RA; Connor AL; Wilding IR; Petereit HU; Schminke C; Beckert T; Cadé D
    Int J Pharm; 2002 Jan; 231(1):83-95. PubMed ID: 11719017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules.
    Ishida M; Abe K; Hashizume M; Kawamura M
    Int J Pharm; 2008 Jul; 359(1-2):46-52. PubMed ID: 18467046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Investigation of the bioadhesion of carbopol and hydroxypropyl methylcellulose to rat gastrointestinal mucosa in vivo and in vitro].
    Zhang ZR; Fu J; Huang Y; Duan YS
    Yao Xue Xue Bao; 2001 Jul; 36(7):543-6. PubMed ID: 12585090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developing hydroxypropyl methylcellulose/hydroxypropyl starch blends for use as capsule materials.
    Zhang L; Wang Y; Liu H; Yu L; Liu X; Chen L; Zhang N
    Carbohydr Polym; 2013 Oct; 98(1):73-9. PubMed ID: 23987318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro and in-vivo erosion profiles of hydroxypropylmethylcellulose (HPMC) matrix tablets.
    Ghimire M; Hodges LA; Band J; O'Mahony B; McInnes FJ; Mullen AB; Stevens HN
    J Control Release; 2010 Oct; 147(1):70-5. PubMed ID: 20600400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study on the impact of hydroxypropyl methylcellulose on the viscosity of PEG melt suspensions using surface plots and principal component analysis.
    Oh CM; Heng PW; Chan LW
    AAPS PharmSciTech; 2015 Apr; 16(2):466-77. PubMed ID: 25370022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scintigraphic evaluation of colon targeting pectin-HPMC tablets in healthy volunteers.
    Hodges LA; Connolly SM; Band J; O'Mahony B; Ugurlu T; Turkoglu M; Wilson CG; Stevens HN
    Int J Pharm; 2009 Mar; 370(1-2):144-50. PubMed ID: 19114096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased intestinal contents viscosity reduces cholesterol absorption efficiency in hamsters fed hydroxypropyl methylcellulose.
    Carr TP; Gallaher DD; Yang CH; Hassel CA
    J Nutr; 1996 May; 126(5):1463-9. PubMed ID: 8618144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Release behavior and photo-image of nifedipine tablet coated with high viscosity grade hydroxypropylmethylcellulose: effect of coating conditions.
    Cao QR; Choi HG; Kim DC; Lee BJ
    Int J Pharm; 2004 Apr; 274(1-2):107-17. PubMed ID: 15072787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of particle size, food, and capsule shell composition on the oral bioavailability of dabrafenib, a BRAF inhibitor, in patients with BRAF mutation-positive tumors.
    Ouellet D; Grossmann KF; Limentani G; Nebot N; Lan K; Knowles L; Gordon MS; Sharma S; Infante JR; Lorusso PM; Pande G; Krachey EC; Blackman SC; Carson SW
    J Pharm Sci; 2013 Sep; 102(9):3100-9. PubMed ID: 23608920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of phenylpropanolamine bioavailability with gastrointestinal transit by scintigraphic monitoring of 111In-labeled hydroxypropylmethylcellulose matrices.
    Feely LC; Davis SS
    Pharm Res; 1989 Apr; 6(4):274-8. PubMed ID: 2748514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a HPMC-based controlled release formulation with hot melt extrusion (HME).
    Ma D; Djemai A; Gendron CM; Xi H; Smith M; Kogan J; Li L
    Drug Dev Ind Pharm; 2013 Jul; 39(7):1070-83. PubMed ID: 22803806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of physicochemical properties of some grades of hydroxypropyl methylcellulose on in vitro mucoadhesion.
    Zhang Q; Li X; Jasti BR
    Int J Pharm; 2021 Nov; 609():121218. PubMed ID: 34687813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the gastrointestinal transit and disintegration behavior of floating and sinking acid-resistant capsules using a novel MRI labeling technique.
    Grimm M; Ball K; Scholz E; Schneider F; Sivert A; Benameur H; Kromrey ML; Kühn JP; Weitschies W
    Eur J Pharm Sci; 2019 Mar; 129():163-172. PubMed ID: 30639530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hard gelatin and hypromellose (HPMC) capsules: estimation of rupture time by real-time dissolution spectroscopy.
    El-Malah Y; Nazzal S; Bottom CB
    Drug Dev Ind Pharm; 2007 Jan; 33(1):27-34. PubMed ID: 17192248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.